PositiveReview/Other2012
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
Classification Results
AI Classification
PositiveFine-tuned Classification
PositiveAI Classification
PositiveFine-tuned Classification
PositivePharmacokinetics of cannabidiol, (-)-trans-Δ9-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs
Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis
PPARα Expression Analysis in a Murine Model of Sepsis-like Inflammation Intestinal Tissue Treated with a Cannabidiol-Enriched Broad Spectrum Cannabis Oil
Orally Administered CBD/CBG Hemp Extract Reduces Severity of Ulcerative Colitis and Pain in a Murine Model
Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances
The use of cannabidiol (CBD) to improve sleep: a systematic review